BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9210608)

  • 1. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
    Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
    J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Terlipressin improves renal function in patients with cirrhosis and ascites without hepatorenal syndrome.
    Krag A; Møller S; Henriksen JH; Holstein-Rathlou NH; Larsen FS; Bendtsen F
    Hepatology; 2007 Dec; 46(6):1863-71. PubMed ID: 18027874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis.
    Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
    López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J
    J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of high dose atrial natriuretic peptide on renal haemodynamics, sodium handling and hormones in cirrhotic patients with and without ascites.
    Jespersen B; Eiskjaer H; Jensen JD; Mogensen CE; Sørensen SS; Pedersen EB
    Scand J Clin Lab Invest; 1995 Jul; 55(4):273-87. PubMed ID: 7569729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic, portal and renal effects of terlipressin in patients with cirrhotic ascites: pilot study.
    Therapondos G; Stanley AJ; Hayes PC
    J Gastroenterol Hepatol; 2004 Jan; 19(1):73-7. PubMed ID: 14675246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.
    Bai Z; An Y; Guo X; Teschke R; Méndez-Sánchez N; Li H; Qi X
    Can J Gastroenterol Hepatol; 2020; 2020():5106958. PubMed ID: 32676484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
    Eiskjaer H; Pedersen EB
    Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome.
    Hadengue A; Gadano A; Moreau R; Giostra E; Durand F; Valla D; Erlinger S; Lebrec D
    J Hepatol; 1998 Oct; 29(4):565-70. PubMed ID: 9824265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.
    Abraham WT; Lauwaars ME; Kim JK; Peña RL; Schrier RW
    Hepatology; 1995 Sep; 22(3):737-43. PubMed ID: 7657277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
    Ginès P; Titó L; Arroyo V; Llach J; Salmerón JM; Ginès A; Jiménez W; Badalamenti S; Rivera F; Rodés J
    Gastroenterology; 1992 Jan; 102(1):280-6. PubMed ID: 1290472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans.
    Swärd K; Valsson F; Sellgren J; Ricksten SE
    Intensive Care Med; 2005 Jan; 31(1):79-85. PubMed ID: 15565364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
    Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
    J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central and systemic haemodynamic effects of terlipressin in portal hypertensive patients.
    Møller S; Hansen EF; Becker U; Brinch K; Henriksen JH; Bendtsen F
    Liver; 2000 Feb; 20(1):51-9. PubMed ID: 10726961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of renal sodium and water excretion in the nephrotic syndrome and cirrhosis of the liver.
    Jespersen B
    Dan Med Bull; 1997 Apr; 44(2):191-207. PubMed ID: 9151012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention.
    La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P
    Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.